SetPoint’s neuromodulation implant wins IDE for multiple sclerosis study
SetPoint Medical has been given an investigational device exemption (IDE) from the US Food and Drug Administration (FDA) greenlighting it …
Post
-
-
Arcus and AstraZeneca enter trial collaboration for renal cancer treatment
Arcus Biosciences has announced a clinical trial partnership with AstraZeneca to assess the combination of casdatifan (AB521) and volrustomig in …
-
UroGen begins subject dosing in Phase III bladder cancer drug trial
UroGen Pharma has announced the dosing of the first subject in the Phase III UTOPIA clinical trial of its investigational …
-
Biostatistics Consulting: Biostatistics Outsourcing Services & Companies in Clinical Research
Biostatistics has found applications in several clinical research fields such as clinical studies, epidemiology, population genetics, and systems biology. Thus, …
-
Exscientia outline robot and AI use in drug discovery workflow
As AI continues to disrupt the healthcare industry, more pharma companies are using algorithms to design drug molecules. AI-driven pharma tech …
-
Barinthus Bio completes enrolment in hepatitis B and prostate cancer vaccine trials
Barinthus Biotherapeutics (formerly Vaccitech) has completed enrolment for its vaccine trials in chronic hepatitis B (CHB) and prostate cancer. The UK-based …
-
Jaguar’s diarrhoea drug shows benefit in Phase III breast cancer subgroup
A diarrhoea drug by Jaguar Health that previously failed in a Phase III oncology trial has shown statistically significant benefit …
-
Perimeter completes enrolment for AI-assisted breast imaging trial
Perimeter Medical Imaging AI has completed enrolment for the pivotal trial of its AI-assisted imaging technology, the Perimeter B-Series OCT …
-
Biogen scrapped stroke drug helps patients walk independently in Phase III trial
A stroke drug scrapped by Biogen has helped more people to walk independently 12 months after a large hemispheric infarction …
-
Navigating the confluence of AI and community-based trials: Is this the solution to improved diversity in clinical research?
Early adoption of artificial intelligence (AI) is already changing the game in clinical trials, with AI enabling some companies to …
-
EmVenio’s clinical research sites at Prime Healthcare hospitals now open in Dallas and Atlanta
EmVenio Research recently announced it has opened two dedicated research centers within the Prime Healthcare hospital system, located in the greater Dallas and Atlanta areas. …
-
EmVenio Research celebrates Prime Healthcare partnership with ribbon-cutting
Clinical research organization EmVenio Research, a PCM Trials company, recently celebrated its partnership with Prime Healthcare in a grand opening event …
-
The course to forging long-term manufacturing partnerships for gene therapies
The current adeno-associated virus (AAV) vector manufacturing landscape in 2024 is a “buyer’s market” with companies competing for clinical trial …
-
A schizophrenia win for BMS’ Cobenfy, but challenges lie ahead
On 26 September 2024, Bristol Myers Squibb (BMS) announced that the US Foof and Drug Administration approved Cobenfy (xanomeline and …
-
Genentech buys Regor’s CDK inhibitors in $850m deal
Genentech is strengthening its oncology pipeline by acquiring Regor Pharmaceuticals’ portfolio of breast cancer cyclin-dependent kinase (CDK) inhibitors in an …
